QCM
CGEM icon

Quantinno Capital Management’s Cullinan Oncology CGEM Stock Holding History

Quantinno Capital Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2M Buy
109,876
+37,594
+52% +$558K ﹤0.01% 1970
2026
Q1 		$1.03M Buy
72,282
+24,281
+51% +$312K ﹤0.01% 2141
2025
Q4 		$497K Sell
48,001
-1,524
-3% -$13.7K ﹤0.01% 2443
2025
Q3 		$294K Buy
+49,525
New +$363K ﹤0.01% 2475

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Quantinno Capital Management's CGEM Position: Q2 2026 in Review

Quantinno Capital Management increased its Cullinan Oncology (CGEM) stake by 52% in Q2 2026, buying an estimated $558K and bringing the position to 109,876 shares worth $2M. The position accounts for ﹤0.01% of the portfolio, ranked #1970.

Quantinno Capital Management first reported a position in CGEM in Q3 2025 and has held it in 4 quarters since. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Quantinno Capital Management held 109,876 shares of Cullinan Oncology worth $2M as of Q2 2026.
  • Quantinno Capital Management bought 37,594 Cullinan Oncology shares in Q2 2026, an estimated $558K.
  • Cullinan Oncology made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1970 holding.
  • Quantinno Capital Management first reported a position in Cullinan Oncology in Q3 2025 and has held it in 4 quarters since.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.